From Westlaw Journal Intellectual Property:Skeptical justices of the U.S. Supreme Court challenged the lawyer for a company whose software patents for a computerized system of creating and exchanging financial instruments have been invalidated to explain why the high court should overrule that decision.
24 Apr 2014Deborah Nathan
Australia-based Alice Corp., a subsidiary of National Australia Bank, sought certiorari in September 2013, asking the Supreme Court to consider the question after the U.S. Court of Appeals for the Federal Circuit invalidated several of its software patents.
Is it a matter of coincidence that the U.S. Patent and Trademark Office published two patents this week focused on aircraft navigation and communications? These inventions, one from Boeing and one from Airbus, are just two examples of the dozens of inventions covering aircraft alert systems, satellite navigation and communications management that have been patented over the last several years. They shine a light on one of the challenges the aerospace industry is working to overcome: how to accurately track flight vehicles wherever and whenever they are. (more…)
Yesterday, A U.S. judge rejected Apple’s request for a permanent sales ban in the U.S. against some older Samsung smartphones. Today’s graphic is a timeline of Apple’s continuing legal battle with Samsung. Apple’s claims on infringements made by Samsung in their original suit are categorized in three groups, highlighted below.
07 Mar 2014Thomson Reuters
Would you like infographics like this on your website, blog or other social media? Contact us and visit our Reuters Agency blog for insights and discussions on the changing media industry.
Teva Pharmaceuticals’ certiorari petition asking the U.S. Supreme Court to decide an appellate court’s proper scope of review of factual findings on claim constructions in a patent case is premature and should not be granted, several generic drug companies say.
04 Mar 2014Deborah Nathan
Sandoz Inc., Momenta Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Mylan Inc. and Natco Pharma Ltd. argue in their brief that Teva’s petition should be denied because the U.S. Court of Appeals for the Federal Circuit has not yet decided the issue.
The U.S. Supreme Court is poised to decide which party has the burden of proof when a party files a declaratory judgment action in a patent case.
13 Nov 2013Deborah Nathan
The high court heard oral argument Nov. 5 by Medtronic Inc. and Boston Scientific Corp., debating whether a licensee filing a declaratory judgment has the burden to prove that its products do not infringe the patents at issue, or whether the patent owner bears the burden of proof that they do.
We are in the middle of a yearlong celebration honoring the 50th anniversary of Derwent World Patents Index® (DWPI℠), a proprietary database of global patent information. Originating in 1963, the Thomson Reuters DWPI database enables professionals to more easily research and understand the world’s innovations through a comprehensive database of more than 23 million inventions detailed in more than 50 million patent documents.
Fifty years ago, Monty Hyams, the now 95-year-old founder of what is today known as DWPI, took on the labor-intensive job of patent research for his customers after he saw them going to the patent office, reading through the patents and classifying them. He realized, “If I can do this, they don’t have to.”
The U.S. Court of Federal Claims has dismissed a patent infringement lawsuit brought by three companies that claim the Defense Department has been using their patented medical imaging invention without permission.
08 Jul 2013Catherine Tomasko
Judge Edward J. Damich said NeuroGrafix, Neurography Institute Medical Associates Inc. and Image-Based Surgicenter Corp. lack standing to pursue their suit against the government.
Our global conference coverage team is made up of scientific specialists and industry professionals. They understand you want comprehensive coverage and you want it now. Which is why we promise to deliver full reports within 28 days of a conference ending — but average 14. Be the first to act on the latest drug pipeline and patents information — with broad conference coverage from Cortellis for Competitive Intelligence.